The Pentagon has spent three years trying to prove it can buy autonomy at the speed adversaries move, first through the Replicator initiative and now through the Defense Autonomous Warfare Group inside SOCOM. The results have been uneven — Replicator 1 delivered "hundreds," not the promised "thousands," of attritable systems by its own 2025 deadline, per the Congressional Research Service. But the acquisition machinery keeps grinding forward: DOD announced its first Replicator 2 award in January, and the Navy keeps signing standalone unmanned-systems and C5ISR task orders regardless of how the flagship initiative is graded politically. That steady drip of task orders, not the marquee program, is the actual mechanism moving money — and it lands on contractors who already hold hulls, sensors, and software integration contracts, not new entrants.
HII's Mission Technologies: The Unsexy Segment Where Navy Autonomy Dollars Actually Land First
While Wall Street prices HII as a two-shipyard cyclical bet on carriers and submarines, its Mission Technologies division is where the Pentagon's push toward unmanned maritime systems and software-defined warfare is already showing up in the numbers.

Mission Technologies grows on task orders measured in months; the shipyards grow on hulls measured in decades — HII investors are pricing the second and getting the first for free.
Who cashes in
HII (Huntington Ingalls Industries) is the direct beneficiary through its Mission Technologies division — separate from the Newport News and Ingalls shipyards that dominate its stock narrative. Mission Technologies posted $748 million in Q1 2026 revenue, up 1.8% year-over-year, driven specifically by C5ISR and unmanned-systems growth, with full-year 2026 guidance of $3.0–$3.2 billion. HII's ROMULUS unmanned surface vessel family and REMUS underwater vehicles — the latter tapped in an April 2026 Defense Innovation Unit award for a submarine-launched torpedo-tube recovery system — put HII in position to sell autonomy hardware without needing a new carrier contract to move the needle.
Leidos (LDOS) rides the same wave from the software-and-integration side. Leidos holds a $248 million Naval Information Warfare Center Pacific contract for unmanned maritime ISR systems and has been publicly validating collaborative-autonomy software on its unmanned surface vessels with the Navy through 2026 — proof the "software-defined warfare" thesis is a real budget line, not a slide-deck buzzword.
BWX Technologies (BWXT) profits from a related but distinct mechanism: the Navy's separate, durable commitment to nuclear propulsion regardless of how autonomy programs shake out. BWXT booked roughly $2.6 billion in FY2026 Naval Nuclear Propulsion Program task orders for Virginia- and Columbia-class submarine and Ford-class carrier reactor components — a backlog that stretches through 2030 and functions as a hedge against any single shipbuilding schedule slip.
General Dynamics (GD), through Electric Boat and Bath Iron Works, captures the submarine and surface-combatant side of the same appropriations, making it the closest pure-play comp to HII's shipyard business — useful as the control group against which Mission Technologies' diversification should be judged.
Who is exposed
Matson (MATX) has no meaningful exposure to this mechanism; it's a Pacific shipping company, not a Navy contractor, and its inclusion in HII's peer set is a reminder that "shipping" and "shipbuilding for the Pentagon" are unrelated trades — don't let sector-adjacent tickers blur the thesis.
The play: The market still prices HII almost entirely on Newport News and Ingalls execution risk — margin compression and cash burn drove HII shares down even after a Q1 2026 revenue beat. Mission Technologies is the segment that can grow when shipyard delivery slips, because it's funded by faster-moving service and technology task orders rather than multi-decade hull contracts. Watch HII's segment-level operating income disclosures, not just top-line Mission Technologies revenue, for confirmation the diversification is margin-accretive, not just volume-accretive.
Source: original report ↗
Free: catalyst alerts, straight to your inbox.
Get the White House orders, federal contracts, and FDA decisions that move money — with who cashes in — free. Unsubscribe in one click.
Free · weekly · unsubscribe anytime. Privacy.
Stay three moves ahead of every practice in your market.
Knowing it happened is table stakes. Money Racket Pro hands you the play — what each move means for your margins, your license, and your patients, and exactly what to do about it — in a two-minute brief, twice a week. The owners who read it never get blindsided.
Get the edge · $40/moJoin the owners who run ahead of the industry. Cancel anytime, one click.